Piribo

Piribo, the online destination for business intelligence for biotech and pharmaceutical industries, has added a new report examining the vulnerable situation Pharmaceutical sector has found itself as a result of new threat posed by generic drugs.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the US hearing aid and implant market.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on would care management and devices in Israel.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the biotechnology market in India.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on investment opportunities in drug delivery in Italy.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report which examines the changing market for telecare for the aged, and analyses the potential impact of Health 2.0.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report showing that the market for wireless and mobile phone based healthcare platforms will grow rapidly.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report analysing the pharmaceutical markets in the E7 countries- Brazil, Russia, India, China, Mexico, Turkey and Indonesia.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report analysing the adherence among pharmaceutical consumers

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which finds that combination pharmaceutical products have gained acceptance.